Literature DB >> 21301094

Crystallization and preliminary X-ray diffraction analysis of a class II phospholipase D from Loxosceles intermedia venom.

Anwar Ullah1, Priscila Oliveira de Giuseppe, Mario Tyago Murakami, Dilza Trevisan-Silva, Ana Carolina Martins Wille, Daniele Chaves-Moreira, Luiza Helena Gremski, Rafael Bertoni da Silveira, Andrea Sennf-Ribeiro, Olga Meiri Chaim, Silvio Sanches Veiga, Raghuvir Krishnaswamy Arni.   

Abstract

Phospholipases D are the major dermonecrotic component of Loxosceles venom and catalyze the hydrolysis of phospholipids, resulting in the formation of lipid mediators such as ceramide-1-phosphate and lysophosphatidic acid which can induce pathological and biological responses. Phospholipases D can be classified into two classes depending on their catalytic efficiency and the presence of an additional disulfide bridge. In this work, both wild-type and H12A-mutant forms of the class II phospholipase D from L. intermedia venom were crystallized. Wild-type and H12A-mutant crystals were grown under very similar conditions using PEG 200 as a precipitant and belonged to space group P12(1)1, with unit-cell parameters a = 50.1, b = 49.5, c = 56.5 Å, β = 105.9°. Wild-type and H12A-mutant crystals diffracted to maximum resolutions of 1.95 and 1.60 Å, respectively.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21301094      PMCID: PMC3034616          DOI: 10.1107/S1744309110050931

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  17 in total

Review 1.  Loxoscelism.

Authors:  J M Futrell
Journal:  Am J Med Sci       Date:  1992-10       Impact factor: 2.378

Review 2.  Brown spiders and loxoscelism.

Authors:  Paulo Henrique da Silva; Rafael Bertoni da Silveira; Márcia Helena Appel; Oldemir Carlos Mangili; Waldemiro Gremski; Silvio Sanches Veiga
Journal:  Toxicon       Date:  2004-12-01       Impact factor: 3.033

3.  The Loxtox protein family in Loxosceles intermedia (Mello-Leitão) venom.

Authors:  E Kalapothakis; M Chatzaki; H Gonçalves-Dornelas; C S de Castro; F G Silvestre; F V Laborne; J F de Moura; S S Veiga; C Chávez-Olórtegui; C Granier; K C Barbaro
Journal:  Toxicon       Date:  2007-07-27       Impact factor: 3.033

Review 4.  Biotechnological applications of brown spider (Loxosceles genus) venom toxins.

Authors:  Andrea Senff-Ribeiro; Paulo Henrique da Silva; Olga Meiri Chaim; Luiza Helena Gremski; Kátia Sabrina Paludo; Rafael Bertoni da Silveira; Waldemiro Gremski; Oldemir Carlos Mangili; Silvio Sanches Veiga
Journal:  Biotechnol Adv       Date:  2007-12-23       Impact factor: 14.227

5.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

6.  Nephrotoxicity caused by brown spider venom phospholipase-D (dermonecrotic toxin) depends on catalytic activity.

Authors:  J Kusma; O M Chaim; A C M Wille; V P Ferrer; Y B Sade; L Donatti; W Gremski; O C Mangili; S S Veiga
Journal:  Biochimie       Date:  2008-08-09       Impact factor: 4.079

7.  Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine.

Authors:  Laurens A van Meeteren; Floor Frederiks; Ben N G Giepmans; Matheus F Fernandes Pedrosa; Stephen J Billington; B Helen Jost; Denise V Tambourgi; Wouter H Moolenaar
Journal:  J Biol Chem       Date:  2004-01-19       Impact factor: 5.157

8.  Identification of a direct hemolytic effect dependent on the catalytic activity induced by phospholipase-D (dermonecrotic toxin) from brown spider venom.

Authors:  Daniele Chaves-Moreira; Olga M Chaim; Youssef B Sade; Kátia S Paludo; Luiza H Gremski; Lucélia Donatti; Juliana de Moura; Oldemir C Mangili; Waldemiro Gremski; Rafael B da Silveira; Andrea Senff-Ribeiro; Silvio S Veiga
Journal:  J Cell Biochem       Date:  2009-07-01       Impact factor: 4.429

9.  Structural insights into the catalytic mechanism of sphingomyelinases D and evolutionary relationship to glycerophosphodiester phosphodiesterases.

Authors:  Mário T Murakami; Matheus Freitas Fernandes-Pedrosa; Sonia A de Andrade; Azat Gabdoulkhakov; Christian Betzel; Denise V Tambourgi; Raghuvir K Arni
Journal:  Biochem Biophys Res Commun       Date:  2006-02-03       Impact factor: 3.575

10.  SMase II, a new sphingomyelinase D from Loxosceles laeta venom gland: molecular cloning, expression, function and structural analysis.

Authors:  Guilherme I de Santi Ferrara; Matheus de F Fernandes-Pedrosa; Inácio de L M Junqueira-de-Azevedo; Rute M Gonçalves-de-Andrade; Fernanda C V Portaro; Daniel Manzoni-de-Almeida; Mário T Murakami; Raghuvir K Arni; Carmen W van den Berg; Paulo L Ho; Denise V Tambourgi
Journal:  Toxicon       Date:  2009-02-26       Impact factor: 3.033

View more
  4 in total

1.  Variable Substrate Preference among Phospholipase D Toxins from Sicariid Spiders.

Authors:  Daniel M Lajoie; Sue A Roberts; Pamela A Zobel-Thropp; Jared L Delahaye; Vahe Bandarian; Greta J Binford; Matthew H J Cordes
Journal:  J Biol Chem       Date:  2015-03-09       Impact factor: 5.157

Review 2.  Highlights in the knowledge of brown spider toxins.

Authors:  Daniele Chaves-Moreira; Andrea Senff-Ribeiro; Ana Carolina Martins Wille; Luiza Helena Gremski; Olga Meiri Chaim; Silvio Sanches Veiga
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-02-08

3.  Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential.

Authors:  Sabrina Karim-Silva; Alessandra Becker-Finco; Isabella Gizzi Jiacomini; Fanny Boursin; Arnaud Leroy; Magali Noiray; Juliana de Moura; Nicolas Aubrey; Philippe Billiald; Larissa M Alvarenga
Journal:  Toxins (Basel)       Date:  2020-04-16       Impact factor: 4.546

4.  Brown Spiders' Phospholipases-D with Potential Therapeutic Applications: Functional Assessment of Mutant Isoforms.

Authors:  Thaís Pereira da Silva; Fernando Jacomini de Castro; Larissa Vuitika; Nayanne Louise Costacurta Polli; Bruno César Antunes; Marianna Bóia-Ferreira; João Carlos Minozzo; Ricardo Barros Mariutti; Fernando Hitomi Matsubara; Raghuvir Krishnaswamy Arni; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Luiza Helena Gremski; Silvio Sanches Veiga
Journal:  Biomedicines       Date:  2021-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.